텍라 라이프사이언스 인베스터스(HQL)는 NYSE에 상장된 Financial Services · Asset Management 기업입니다. 현재가 $19.39 (-0.92%), 시가총액 $0.54B, PER (주가수익비율) 6.33, 52주 최저~최고 $12.17 ~ $18.22.
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management,
텍라 라이프사이언스 인베스터스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
텍라 라이프사이언스 인베스터스의 현재 주가는 $19.39 (-0.92%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
텍라 라이프사이언스 인베스터스의 시가총액은 약 $0.54B입니다. PER은 6.33입니다.
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of compan